(MTRN) Materion - Ratings and Ratios
Beryllium, Alloys, Composites, Coatings, Chemicals
EPS (Earnings per Share)
Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 39.2% |
| Value at Risk 5%th | 57.5% |
| Relative Tail Risk | -10.79% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.16 |
| Alpha | -11.95 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.301 |
| Beta | 1.075 |
| Beta Downside | 1.117 |
| Drawdowns 3y | |
|---|---|
| Max DD | 47.84% |
| Mean DD | 16.98% |
| Median DD | 15.09% |
Description: MTRN Materion November 10, 2025
Materion Corporation (NYSE:MTRN) is a global producer of advanced engineered materials, operating through four segments-Performance Materials, Electronic Materials, Precision Optics, and Other-serving semiconductor, aerospace & defense, automotive, energy, consumer electronics, and life-science markets. Its product portfolio spans beryllium and non-beryllium alloys, ToughMet and SupremEX metal-matrix composites, precision thin-film coatings, optical filters, and specialty chemicals, with a vertically integrated beryllium supply chain that includes the Bertrandite ore mine and refinery.
Key economic drivers for Material include rising defense spending (which boosts demand for lightweight beryllium alloys), sustained growth in semiconductor packaging (estimated 8% CAGR through 2027), and the automotive industrys shift toward lightweighting for electric-vehicle efficiency. These macro trends translate into higher utilization of the company’s high-performance alloys and metal-matrix composites.
According to its FY 2023 filing, Materion generated roughly $1.2 billion in revenue with an adjusted EBITDA margin of ~13%, while beryllium hydroxide prices have risen ~25% year-over-year, reflecting tight supply and strong defense demand. The Precision Optics segment posted a 12% revenue increase, driven by higher orders for optical filters used in aerospace and medical imaging.
For a deeper quantitative assessment of Materion’s valuation and risk profile, you may find it useful to explore the detailed analytics available on ValueRay.
MTRN Stock Overview
| Market Cap in USD | 2,374m |
| Sub-Industry | Diversified Metals & Mining |
| IPO / Inception | 1984-09-07 |
| Return 12m vs S&P 500 | -9.13% |
| Analyst Rating | 4.0 of 5 |
MTRN Dividends
| Metric | Value |
|---|---|
| Dividend Yield | 0.49% |
| Yield on Cost 5y | 0.94% |
| Yield CAGR 5y | 4.13% |
| Payout Consistency | 70.6% |
| Payout Ratio | 10.2% |
MTRN Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | 13.27% |
| CAGR/Max DD Calmar Ratio | 0.28 |
| CAGR/Mean DD Pain Ratio | 0.78 |
| Current Volume | 107.3k |
| Average Volume | 121.4k |
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (19.4m TTM) > 0 and > 6% of Revenue (6% = 103.6m TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA 5.19pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 31.30% (prev 32.51%; Δ -1.21pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.09 (>3.0%) and CFO 157.1m > Net Income 19.4m (YES >=105%, WARN >=100%) |
| Net Debt (515.3m) to EBITDA (211.8m) ratio: 2.43 <= 3.0 (WARN <= 3.5) |
| Current Ratio 3.29 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (20.9m) change vs 12m ago -0.13% (target <= -2.0% for YES) |
| Gross Margin 19.20% (prev 18.56%; Δ 0.64pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 94.64% (prev 89.86%; Δ 4.78pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.58 (EBITDA TTM 211.8m / Interest Expense TTM 31.5m) >= 6 (WARN >= 3) |
Altman Z'' 5.64
| (A) 0.30 = (Total Current Assets 776.3m - Total Current Liabilities 235.6m) / Total Assets 1.79b |
| (B) 0.51 = Retained Earnings (Balance) 908.7m / Total Assets 1.79b |
| (C) 0.08 = EBIT TTM 144.5m / Avg Total Assets 1.83b |
| (D) 1.40 = Book Value of Equity 1.20b / Total Liabilities 858.6m |
| Total Rating: 5.64 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 58.97
| 1. Piotroski 6.50pt |
| 2. FCF Yield 2.72% |
| 3. FCF Margin 4.56% |
| 4. Debt/Equity 0.57 |
| 5. Debt/Ebitda 2.43 |
| 6. ROIC - WACC (= 1.31)% |
| 7. RoE 2.15% |
| 8. Rev. Trend 24.62% |
| 9. EPS Trend -4.03% |
What is the price of MTRN shares?
Over the past week, the price has changed by -3.20%, over one month by -15.33%, over three months by +3.77% and over the past year by +1.64%.
Is MTRN a buy, sell or hold?
- Strong Buy: 1
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the MTRN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 143.7 | 26.5% |
| Analysts Target Price | 143.7 | 26.5% |
| ValueRay Target Price | 122.6 | 7.9% |
MTRN Fundamental Data Overview November 21, 2025
P/E Trailing = 121.8085
P/E Forward = 17.9856
P/S = 1.3693
P/B = 2.5254
P/EG = 2.35
Beta = 0.874
Revenue TTM = 1.73b USD
EBIT TTM = 144.5m USD
EBITDA TTM = 211.8m USD
Long Term Debt = 446.8m USD (from longTermDebt, last quarter)
Short Term Debt = 10.2m USD (from shortTermDebt, last quarter)
Debt = 531.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 515.3m USD (from netDebt column, last quarter)
Enterprise Value = 2.89b USD (2.37b + Debt 531.7m - CCE 16.4m)
Interest Coverage Ratio = 4.58 (Ebit TTM 144.5m / Interest Expense TTM 31.5m)
FCF Yield = 2.72% (FCF TTM 78.7m / Enterprise Value 2.89b)
FCF Margin = 4.56% (FCF TTM 78.7m / Revenue TTM 1.73b)
Net Margin = 1.12% (Net Income TTM 19.4m / Revenue TTM 1.73b)
Gross Margin = 19.20% ((Revenue TTM 1.73b - Cost of Revenue TTM 1.40b) / Revenue TTM)
Gross Margin QoQ = 18.19% (prev 19.15%)
Tobins Q-Ratio = 1.61 (Enterprise Value 2.89b / Total Assets 1.79b)
Interest Expense / Debt = 1.57% (Interest Expense 8.34m / Debt 531.7m)
Taxrate = 9.60% (2.70m / 28.1m)
NOPAT = 130.6m (EBIT 144.5m * (1 - 9.60%))
Current Ratio = 3.29 (Total Current Assets 776.3m / Total Current Liabilities 235.6m)
Debt / Equity = 0.57 (Debt 531.7m / totalStockholderEquity, last quarter 934.6m)
Debt / EBITDA = 2.43 (Net Debt 515.3m / EBITDA 211.8m)
Debt / FCF = 6.55 (Net Debt 515.3m / FCF TTM 78.7m)
Total Stockholder Equity = 900.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.08% (Net Income 19.4m / Total Assets 1.79b)
RoE = 2.15% (Net Income TTM 19.4m / Total Stockholder Equity 900.5m)
RoCE = 10.72% (EBIT 144.5m / Capital Employed (Equity 900.5m + L.T.Debt 446.8m))
RoIC = 9.71% (NOPAT 130.6m / Invested Capital 1.34b)
WACC = 8.40% (E(2.37b)/V(2.91b) * Re(9.97%) + D(531.7m)/V(2.91b) * Rd(1.57%) * (1-Tc(0.10)))
Discount Rate = 9.97% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.10%
[DCF Debug] Terminal Value 62.28% ; FCFE base≈78.7m ; Y1≈51.7m ; Y5≈23.6m
Fair Price DCF = 16.82 (DCF Value 348.7m / Shares Outstanding 20.7m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -4.03 | EPS CAGR: -1.99% | SUE: 2.91 | # QB: 4
Revenue Correlation: 24.62 | Revenue CAGR: 0.32% | SUE: -0.56 | # QB: 0
Additional Sources for MTRN Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle